CBT-006

N/A

Report date: 2022/08/23 17:53:56

Base Information

Drug NameCBT-006
Drug Alias NameCBT-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol inhibitors
TargetsCholesterol
Therapy Area/IndicationsMeibomian Gland Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCloudbreak Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCloudbreak Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsMeibomian Gland Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A